(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.67%.
Pepgen's earnings in 2026 is -$93,557,000.On average, 8 Wall Street analysts forecast PEPG's earnings for 2026 to be -$92,796,353, with the lowest PEPG earnings forecast at -$140,810,112, and the highest PEPG earnings forecast at -$62,801,503. On average, 6 Wall Street analysts forecast PEPG's earnings for 2027 to be -$77,135,507, with the lowest PEPG earnings forecast at -$94,322,563, and the highest PEPG earnings forecast at -$48,364,376.
In 2028, PEPG is forecast to generate -$42,424,529 in earnings, with the lowest earnings forecast at -$50,529,945 and the highest earnings forecast at -$33,205,392.